AiOmed

Company Overview

Snapshot

Founded in January 2022 by Keren Lipshitz, Leonid Remennik, and Daniel Kofman, AiOmed operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on developing its Patient Health LearningTM product.

Business overview

AiOmed provides an all-in-one remote patient monitoring solution designed for senior living and assisted living individuals. The company's core technology offers tools and insights to monitor patients, prevent health deterioration, automate care processes, and enhance overall care quality. Operating within the Health Tech & Life Sciences sector, AiOmed serves the digital healthcare market, specifically focusing on patient remote monitoring solutions for providers and patients.

Strategic signal

In November 2022, AiOmed's co-founder and CEO, Keren Lipshitz, highlighted the critical need for advanced care solutions, stating that "70% of us will need care at a certain age in our lives." This statement underscores the company's strategic focus on addressing a significant and growing demographic challenge within the healthcare industry, signaling a strong market-driven approach to its remote patient monitoring solutions.

Company Intelligence Q&A

When was AiOmed founded?

AiOmed was founded in January 2022.

Who are the founders of AiOmed?

AiOmed was founded by Keren Lipshitz, Leonid Remennik, and Daniel Kofman.

What is AiOmed's primary product?

AiOmed's primary product is Patient Health LearningTM, an all-in-one remote patient monitoring solution.

What market does AiOmed primarily serve?

AiOmed primarily serves the digital healthcare market, focusing on senior living and assisted living individuals.

What is AiOmed's current funding stage?

AiOmed is currently in the Pre-Funding stage, indicating it has not yet raised external capital.